34.26
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché VKTX Giù?
Forum
Previsione
Viking Therapeutics Inc Borsa (VKTX) Ultime notizie
Morgan Stanley reiterates Viking Therapeutics stock rating on trial progress - Investing.com
Viking Therapeutics Moves Closer To Challenging Ozempic With Phase 3 Trial Progress - Stocktwits
Viking Therapeutics completes enrollment in obesity drug trial - Investing.com
Viking Therapeutics Announces Completion of Enrollment in Phase 3 VANQUISH-2 Trial of VK2735 - PR Newswire
Meadowbrook Wealth Management LLC Invests $1.31 Million in Viking Therapeutics, Inc. $VKTX - MarketBeat
Viking Therapeutics Secures Manufacturing Might Ahead of Pivotal Data - AD HOC NEWS
Assessing Viking Therapeutics (VKTX) Valuation As Clinical Pipeline Progress Shapes Investor Expectations - simplywall.st
Viking Therapeutics, Inc. (VKTX) latest stock news and headlines - Yahoo Finance Singapore
Why Shares of Viking Therapeutics, Inc. (VKTX) Fell More Sharply Than the Overall Market Today - Bitget
Why Viking Therapeutics, Inc. (VKTX) Dipped More Than Broader Market Today - Yahoo Finance Singapore
Viking Therapeutics: Can Its Obesity Drug Pipeline Justify a Multi-Billion Dollar Valuation? - AD HOC NEWS
Why Viking Therapeutics Stock Could Take Off Later This Year - The Motley Fool
Viking Therapeutics: An Equally Important Catalyst Ahead (NASDAQ:VKTX) - Seeking Alpha
HC Wainwright Reiterates "Buy" Rating for Viking Therapeutics (NASDAQ:VKTX) - MarketBeat
Viking Therapeutics (VKTX) Receives Reiterated "Buy" Rating from HC Wainwright & Co. | VKTX Stock News - GuruFocus
Does Viking Therapeutics (NASDAQ:VKTX) Show Stability In The Nasdaq 100 Index? - Kalkine Media
Better Weight Loss Drug Stock Buy: Eli Lilly vs Viking Therapeutics - AOL.com
Got $1,500? Is It Better to Buy Bitcoin, or Viking Therapeutics? - The Motley Fool
Profit Investment Management LLC Sells 58,559 Shares of Viking Therapeutics, Inc. $VKTX - MarketBeat
Trading Systems Reacting to (VKTX) Volatility - Stock Traders Daily
Morgan Stanley Maintains Viking Therapeutics (VKTX) Overweight Recommendation - MSN
Viking Therapeutics, Inc. (VKTX) rises higher than market: Key facts - MSN
Viking Therapeutics, Inc.: Fundamental Analysis and Financial Ratings | 1VKTX | US92686J1060 - marketscreener.com
Viking Therapeutics: Phase 3 Obesity Data Feels Like A Coin Toss (Rating Downgrade) (VKTX) - Seeking Alpha
VIKING THERAPEUTICS, INC. (VKTX) - MSN
BTIG Reiterates a Buy Rating on Viking Therapeutics (VKTX) With a $125 PT - MSN
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):